Multicenter trials using 18F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: Effects of differential measurement error and bias on power calculations for unselected and enrichment designs.
CONCLUSION: Even moderate additional measurement error substantially reduced study power under both unselected and enrichment designs.
PMID: 24169628 [PubMed - as supplied by publisher]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Kurland BF, Doot RK, Linden HM, Mankoff DA, Kinahan PE Tags: Clin Trials Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | PET Scan | Study